Skip to main content
BIO logo

BIO · Bio-Rad Laboratories, Inc. · Debt

Track BIO — free
$372.18 -12.22 (-3.18%) At close · Oct 30 Q2 2026 earnings call transcript
Market Cap
$9.95B
Shares
26.74M
Volume · Oct 30 183.13K Avg daily vol (3M) 254.36K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Finance lease liabilities 2026-06-30 USD 8,900,000 10-Q filed 2026-08-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current finance lease liabilities
USD 500,000
Noncurrent finance lease liabilities
USD 8,400,000
Long-term debt, including current maturities 2026-06-30 USD 1,203,700,000 10-Q filed 2026-08-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of other long-term debt
USD 400,700,000
Noncurrent debt carrying amount
USD 803,000,000
Operating lease liabilities 2026-06-30 USD 166,700,000 10-Q filed 2026-08-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 33,600,000
Noncurrent operating lease liabilities
USD 133,100,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 12208 CUSIP 090572207 13F (30d) 147 filings 120 filers Visit website Investor relations